Working… Menu

Efficacy and Safety of Moxonidine in Indian Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00160277
Recruitment Status : Completed
First Posted : September 12, 2005
Last Update Posted : January 30, 2009
Information provided by:
Solvay Pharmaceuticals

Brief Summary:
The purpose of this study is to demonstrate efficacy and safety of Moxonidine in Indian subjects.

Condition or disease Intervention/treatment Phase
Hypertension Drug: Moxonidine Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 100 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Open Label, Multi-Center, Force-Titration Study to Evaluate the Efficacy and Safety of Moxonidine in Ambulatory Subjects With Essential Hypertension
Study Start Date : July 2005

Resource links provided by the National Library of Medicine

Primary Outcome Measures :
  1. Systolic blood pressure reduction

Secondary Outcome Measures :
  1. Piggy-back pharmacoeconomic evaluation; Safety and tolerability

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:


Exclusion Criteria:

Severe concomitant diseases, CHF, secondary hypertension, severe hypertension, significant hepatic disease, unstable angina

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00160277

Layout table for location information
Site 1
Jubillee Hills Hyderabad, India
Site 2
Mangalore, India
Site 3
New Delhi, India
Sponsors and Collaborators
Solvay Pharmaceuticals
Layout table for investigator information
Study Director: Global Clinical Director Solvay Solvay Pharmaceuticals
Layout table for additonal information Identifier: NCT00160277    
Other Study ID Numbers: S220.3.124
First Posted: September 12, 2005    Key Record Dates
Last Update Posted: January 30, 2009
Last Verified: January 2009
Keywords provided by Solvay Pharmaceuticals:
Efficacy and safety of moxonidine in Indian hypertensives
Additional relevant MeSH terms:
Layout table for MeSH terms
Vascular Diseases
Cardiovascular Diseases
Antihypertensive Agents